Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,869 Cr₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹8,869 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,869 Cr
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2026 ₹8,869 Cr
-3.08
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹32,570.3 Cr -0.6% 26.2% 25.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,291.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹305,014.0 Cr 3.7% 27.2% 71.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,333.0 Cr -2.3% 1.5% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,017.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,539.0 Cr -1.3% 6.1% -6.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.6%

26.2%

25.5%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses